151 related articles for article (PubMed ID: 37085442)
1. Redefining the paradigm of immunization in immunocompromised post-pandemic patients.
Fernández-Prada M; Campins-Martí M; Tamames-Gómez S
Enferm Infecc Microbiol Clin (Engl Ed); 2023 Oct; 41(8):524-525. PubMed ID: 37085442
[No Abstract] [Full Text] [Related]
2. Strategies and safety considerations of booster vaccination in COVID-19.
Meng H; Mao J; Ye Q
Bosn J Basic Med Sci; 2022 Jun; 22(3):366-373. PubMed ID: 35366790
[TBL] [Abstract][Full Text] [Related]
3. Vaccination and immunization against travel-related diseases in immunocompromised hosts.
Kotton CN
Expert Rev Vaccines; 2008 Jul; 7(5):663-72. PubMed ID: 18564020
[TBL] [Abstract][Full Text] [Related]
4. 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host.
Rubin LG; Levin MJ; Ljungman P; Davies EG; Avery R; Tomblyn M; Bousvaros A; Dhanireddy S; Sung L; Keyserling H; Kang I;
Clin Infect Dis; 2014 Feb; 58(3):309-18. PubMed ID: 24421306
[TBL] [Abstract][Full Text] [Related]
5. 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host.
Rubin LG; Levin MJ; Ljungman P; Davies EG; Avery R; Tomblyn M; Bousvaros A; Dhanireddy S; Sung L; Keyserling H; Kang I;
Clin Infect Dis; 2014 Feb; 58(3):e44-100. PubMed ID: 24311479
[TBL] [Abstract][Full Text] [Related]
6. How ready was the US vaccination infrastructure and network of immunization information systems for COVID-19 vaccination campaigns: Recommendations to strengthen the routine vaccination program and prepare for the next pandemic.
Shen AK; Sobczyk EA; Coyle R; Tirmal A; Hannan C
Hum Vaccin Immunother; 2022 Nov; 18(5):2088010. PubMed ID: 35796624
[TBL] [Abstract][Full Text] [Related]
7. Immunization against infectious disease in adult oncology.
Fairlamb DJ
Clin Oncol (R Coll Radiol); 1992 May; 4(3):139-40. PubMed ID: 1586630
[No Abstract] [Full Text] [Related]
8. Immunization of immunocompromised persons.
Weber DJ; Rutala WA
Immunol Allergy Clin North Am; 2003 Nov; 23(4):605-34, v-vi. PubMed ID: 14753383
[TBL] [Abstract][Full Text] [Related]
9. Immunization stress-related responses: Implications for vaccination hesitancy and vaccination processes during the COVID-19 pandemic.
Taylor S; Asmundson GJG
J Anxiety Disord; 2021 Dec; 84():102489. PubMed ID: 34627104
[No Abstract] [Full Text] [Related]
10. [IMMUNIZATIONS IN IMMUNOCOMPROMISED HOSTS--PRINCIPLES AND UPDATED RECOMMENDATIONS].
Hershman-Sarafov M; Potasman I
Harefuah; 2015 Dec; 154(12):786-90, 804, 803. PubMed ID: 26897782
[TBL] [Abstract][Full Text] [Related]
11. Childhood immunization during the COVID-19 pandemic: experiences in Haiti, Lesotho, Liberia and Malawi.
Connolly E; Boley EJ; Fejfar DL; Varney PF; Aron MB; Fulcher IR; Lambert W; Ndayizigiye M; Law MR; Mugunga JC; Hedt-Gauthier B;
Bull World Health Organ; 2022 Feb; 100(2):115-126C. PubMed ID: 35125536
[TBL] [Abstract][Full Text] [Related]
12. Vaccination of the immunocompromised patient.
Loutan L
Biologicals; 1997 Jun; 25(2):231-6. PubMed ID: 9236058
[TBL] [Abstract][Full Text] [Related]
13. Italian immunization calendar implementation: Time to optimize number of vaccination appointments?
Poscia A; Lo Giudice M; Nigri L; Perone V; Russo R; Bresesti I; Agosti M
Hum Vaccin Immunother; 2023 Dec; 19(1):2156745. PubMed ID: 36876458
[TBL] [Abstract][Full Text] [Related]
14. [Antiviral immunization of immunocompromised adults, literature review].
Duchet Niedziolka P; Launay O; Salmon Ceron D; Consigny PH; Ancelle T; Van der Vliet D; Lortholary O; Hanslik T;
Rev Med Interne; 2008 Jul; 29(7):554-67. PubMed ID: 17942195
[TBL] [Abstract][Full Text] [Related]
15. Immune responsiveness and protective immunity after transplantation.
Gangappa S; Kokko KE; Carlson LM; Gourley T; Newell KA; Pearson TC; Ahmed R; Larsen CP
Transpl Int; 2008 Apr; 21(4):293-303. PubMed ID: 18225995
[TBL] [Abstract][Full Text] [Related]
16. Impact of the COVID-19 pandemic on routine immunization services in Yerevan and vaccinations against COVID-19 in Armenia.
Melkonyan N; Badalyan A; Hovhannisyan H; Poghosyan K
J Infect Dev Ctries; 2022 Nov; 16(11):1687-1695. PubMed ID: 36449639
[TBL] [Abstract][Full Text] [Related]
17. [Influenza vaccination of immunocompromised patients: safe and effective].
Opstelten W; Rimmelzwaan GF; van Essen GA; Bijlsma JW
Ned Tijdschr Geneeskd; 2009; 153():A902. PubMed ID: 19857314
[TBL] [Abstract][Full Text] [Related]
18. Developing COVID-19 vaccine recommendations during the pandemic: The experience of Serbia's Expert Committee on Immunization.
Markovic-Denic L; Popadic D; Jovanovic T; Bonaci-Nikolic B; Samardzic J; Tomic Spiric V; Rancic M; Sankar Datta S; Mosina L; Jancic J; Vukomanovic G; Jovanovic V; Vukomanovic V; Antic D; Veljkovic M; Saponjic V; Jacques-Carroll L
Front Public Health; 2022; 10():1056670. PubMed ID: 36466511
[TBL] [Abstract][Full Text] [Related]
19. Impact of COVID-19 pandemic on routine immunization.
Ota MOC; Badur S; Romano-Mazzotti L; Friedland LR
Ann Med; 2021 Dec; 53(1):2286-2297. PubMed ID: 34854789
[TBL] [Abstract][Full Text] [Related]
20. Impact of the COVID-19 pandemic on the provision of routine childhood immunizations in Ontario, Canada.
Piché-Renaud PP; Ji C; Farrar DS; Friedman JN; Science M; Kitai I; Burey S; Feldman M; Morris SK
Vaccine; 2021 Jul; 39(31):4373-4382. PubMed ID: 34108076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
